{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T02:31:40Z","timestamp":1777084300346,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1995,5,1]],"date-time":"1995-05-01T00:00:00Z","timestamp":799286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[1995,5]]},"DOI":"10.1007\/bf02530129","type":"journal-article","created":{"date-parts":[[2006,11,15]],"date-time":"2006-11-15T00:27:05Z","timestamp":1163550425000},"page":"117-123","source":"Crossref","is-referenced-by-count":1,"title":["Kontinuierliche subkutane Buprenorphinapplikation in der Therapie karzinombedingter Schmerzen","Continuous subcutaneous buprenorphine application in the treatment of cancer pain"],"prefix":"10.1007","volume":"9","author":[{"given":"I.","family":"Gralow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Frhr","family":"von Hornstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Schleyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Hiddemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02530129_CR1","first-page":"305","volume":"3","author":"E Alon","year":"1983","unstructured":"Alon E (1983) Clinical pharmacology and toxicology of analgesic drugs: buprenorphine\u2014recent information. Pharmacol Basis Anestesiol 3: 305","journal-title":"Pharmacol Basis Anestesiol"},{"key":"BF02530129_CR2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0378-4347(85)80073-6","volume":"338","author":"Y Blom","year":"1985","unstructured":"Blom Y, Bondesson U, \u00c4nggard E (1985) Analysis of buprenorphine and its n-dealkylated metabolite in plasma and urine by selected-ion monitoring. J Chromatogr 338: 89","journal-title":"J Chromatogr"},{"key":"BF02530129_CR3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/bja\/57.2.192","volume":"57","author":"RA Boas","year":"1985","unstructured":"Boas RA, Villiger JW (1985) Clinical actions of fentanyl and buprenorphine. Br J Anaesth 57: 192","journal-title":"Br J Anaesth"},{"key":"BF02530129_CR4","first-page":"1172","volume":"126","author":"I Bowdler","year":"1984","unstructured":"Bowdler I, Ko\u00dfmann B, Erdle H-P, Kilian J (1984) Theoretische Grundlagen und Therapie-Erfahrungen mit Buprenorphin-SL. M\u00fcnchner Med Wochenschrift 126: 1172","journal-title":"M\u00fcnchner Med Wochenschrift"},{"key":"BF02530129_CR5","first-page":"635","volume":"71","author":"E Bruera","year":"1987","unstructured":"Bruera E, Brenneis C, Michaud M, Chadwick S, MacDonald RN (1987) Continuous sc infusion of narcotics using a portable disposable device in patients with advanced cancer. Cancer Treat Rev 71: 635","journal-title":"Cancer Treat Rev"},{"key":"BF02530129_CR6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/clpt.1980.219","volume":"28","author":"RES Bullingham","year":"1980","unstructured":"Bullingham RES, McQuay HJ, Moore RA, Bennett MRD (1980) Buprenorphine kinetics. Clin Pharmacol Ther 28: 667","journal-title":"Clin Pharmacol Ther"},{"key":"BF02530129_CR7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2125.1981.tb01190.x","volume":"12","author":"RES Bullingham","year":"1981","unstructured":"Bullingham RES, McQuay HJ, Dwyer D, Allen MC, Moore RA (1981) Sublingual buprenorphine used postoperatively: clinical observations and preliminary pharmacokinetic analysis. Br J Clin Pharmacol 12: 123","journal-title":"Br J Clin Pharmacol"},{"key":"BF02530129_CR8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2125.1982.tb01434.x","volume":"13","author":"RES Bullingham","year":"1982","unstructured":"Bullingham RES, McQuay HJ, Porter EJB, Allen MC, Moore RA (1982) Sublingual buprenorphine used postoperatively: ten hour plasma drug concentration analysis. Br J Clin Pharmacol 13: 665","journal-title":"Br J Clin Pharmacol"},{"key":"BF02530129_CR9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2165\/00003088-198308040-00004","volume":"8","author":"RES Bullingham","year":"1983","unstructured":"Bullingham RES, McQuay HJ, Moore RA (1983) Clinical pharmacokinetics of narcotic agonist-antagonist drugs. Clin Pharmacokinet 8: 332","journal-title":"Clin Pharmacokinet"},{"key":"BF02530129_CR10","first-page":"577","volume":"12","author":"EJ Cone","year":"1984","unstructured":"Cone EJ, Gorodetzky CW, Yousefnejad D, Buchwald WF, Johnson RE (1984) The metabolism and excretion of buprenorphine in humans. Drug Metab Dispos 12: 577","journal-title":"Drug Metab Dispos"},{"key":"BF02530129_CR11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF02527636","volume":"7","author":"H Goecke","year":"1993","unstructured":"Goecke H, Herbst M (1993) Ambulante kontinuierliche subkutane opioidanalgesie als PCAO (Patient controlled analgesia in outpatients) bei schweren Tumorschmerzen. Der Schmerz 7: 31","journal-title":"Der Schmerz"},{"key":"BF02530129_CR12","first-page":"147","volume":"11","author":"I Gralow","year":"1990","unstructured":"Gralow I, Hornstein von W, Moerchel O, Lawin P (1990) Kontinuierliche subkutane Morphingabe mittels eines externen tragbaren Infusorsystems bei inkurablen Kopf-Hals-Tumoren: Pilotstudie. Eur J Pain 11: 147","journal-title":"Eur J Pain"},{"key":"BF02530129_CR13","series-title":"Das \u00abTop fit\u00bb Pharmakokinetik-Computer-Programm ist \u00fcber die Firmen: Goedecke, Schering und Thomae zu beziehen)","volume-title":"Pharmacokinetics during drug development: Data analyses and evaluation techniques","year":"1982","unstructured":"Heinzel G, Bozler G, Rossum JM van (eds) (1982) Pharmacokinetics during drug development: Data analyses and evaluation techniques. Gustav Fischer Verlag. Stuttgart New York (Das \u00abTop fit\u00bb Pharmakokinetik-Computer-Programm ist \u00fcber die Firmen: Goedecke, Schering und Thomae zu beziehen)"},{"key":"BF02530129_CR14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003495-197917020-00001","volume":"17","author":"RC Heel","year":"1979","unstructured":"Heel RC, Brodgen RN, Speght TM, Avery GS (1979) Buprenorphine: A review of its pharmacological properties and therapeutic efficiacy. Drugs 17: 81","journal-title":"Drugs"},{"key":"BF02530129_CR15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF02527770","volume":"2","author":"G Hotz","year":"1988","unstructured":"Hotz G (1988) Tumorschmerztherapie im Mund-Kiefer-Gesichtsbereich mit Buprenorphin-Sublingualtabletten. Der Schmerz 2: 38","journal-title":"Der Schmerz"},{"key":"BF02530129_CR16","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archpsyc.1978.01770280111012","volume":"35","author":"DR Jasinski","year":"1978","unstructured":"Jasinski DR, Pevnik JS, Griffith JD (1978) Human pharmacology and abuse potential of the analgesic buprenorphine. Arch Gen Psychiatry 35: 501","journal-title":"Arch Gen Psychiatry"},{"key":"BF02530129_CR17","first-page":"267","volume":"8","author":"JW Lewis","year":"1986","unstructured":"Lewis JW (1986) Pharmacological profile of buprenorphine and its clinical use in cancer pain. Adv Pain Res Ther 8: 267","journal-title":"Adv Pain Res Ther"},{"key":"BF02530129_CR18","first-page":"271","volume":"8","author":"HJ McQuay","year":"1986","unstructured":"McQuay HJ, Moore RA, Bullingham RES (1986) Buprenorphine kinetics Adv Pain Res Ther 8: 271","journal-title":"Adv Pain Res Ther"},{"key":"BF02530129_CR19","first-page":"407","volume":"8","author":"HJ McQuay","year":"1986","unstructured":"McQuay HJ, Moore RA, Bullingham RES (1986) Sublingual morphine, heroine, methadone and buprenorphin: kinetics and effects. Adv Pain Res Ther 8: 407","journal-title":"Adv Pain Res Ther"},{"key":"BF02530129_CR20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0731-7085(87)80035-3","volume":"5","author":"G Mullersmann","year":"1987","unstructured":"Mullersmann G, Toufflin S, Derendorf H (1987) HPLC analysis of buprenorphine in plasma and urine using coulometric detection. J. Pharmaceut Biomed Anal 5: 303","journal-title":"J. Pharmaceut Biomed Anal"},{"key":"BF02530129_CR21","first-page":"261","volume":"34","author":"J Noda","year":"1985","unstructured":"Noda J, Kojima T (1985) Quantitative determination of buprenorphine in human plasma by high-performance liquid chromatography. Hiroshima J Med Sci 34: 261","journal-title":"Hiroshima J Med Sci"},{"key":"BF02530129_CR22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00002508-198906000-00004","volume":"5","author":"J Noda","year":"1989","unstructured":"Noda J, Umeda S, Arai T, Harima A, Mori M (1989) Continuous subcutaneous infusion of buprenorphine for cancer pain control. Clin J Pain 5: 147","journal-title":"Clin J Pain"},{"key":"BF02530129_CR23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0378-4347(00)83057-1","volume":"487","author":"M Ohtani","year":"1989","unstructured":"Ohtani M, Shibuya F, Kotaki H, Uchino K, Saitoh Y, Nakagawa F, Nishitateno K (1989) Quantitative determination of buprenorphine and its active metabolite, norbuprenorphine, in human plasma by gas chromatography-chemical ionization mass spectrometry. J Chromatogr 487: 469","journal-title":"J Chromatogr"},{"key":"BF02530129_CR24","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.2042-7158.1988.tb05336.x","volume":"40","author":"JE Olley","year":"1988","unstructured":"Olley JE, Tiong KL (1988) Plasma levels of opioid material in man following sublingual and intravenous administration of buprenorphine: exogenous\/endogenous opioid interaction? J Pharm Pharmacol 40: 666","journal-title":"J Pharm Pharmacol"},{"key":"BF02530129_CR25","first-page":"601","volume":"32","author":"S Piepenbrock","year":"1983","unstructured":"Piepenbrock S, Zenz M, Gorus R, Link J, Reinhart K (1983) Buprenorphin und Pentazocin zur postoperativen Analgesie. An\u00e4sthesist 32: 601","journal-title":"An\u00e4sthesist"},{"key":"BF02530129_CR26","first-page":"61","volume":"5","author":"C Rossano","year":"1982","unstructured":"Rossano C, Luca LF de, Firetto V, Fossi F, Castiglioni CL, Carminati P (1982) Activity and tolerability of buprenorphine after parenteral and sublingual administration. Clin Ther 5: 61","journal-title":"Clin Ther"},{"key":"BF02530129_CR27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0378-4347(93)80319-Y","volume":"614","author":"E Schleyer","year":"1993","unstructured":"Schleyer E, Lohmann R, Rolf C, Gralow I, Kaufmann CC, Unterhalt M, Hiddemann W (1993) Column-switching solid-phase trace-enrichment high-performance liquid chromatographic method for measurement of buprenorphine and norbuprenorphine in human plasma and urine by electrochemical detection. J Chromatogr 614: 275","journal-title":"J Chromatogr"},{"key":"BF02530129_CR28","first-page":"202","volume":"338","author":"GKL Tiong","year":"1988","unstructured":"Tiong GKL, Olley JE (1988) Enzyme immunoassay of buprenorphine. Arch Pharmacol 338: 202","journal-title":"Arch Pharmacol"},{"key":"BF02530129_CR29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1213\/00000539-198903000-00036","volume":"68","author":"SD Waldman","year":"1989","unstructured":"Waldman SD, Coombs DW (1989) Selection of implantable narcotic delivery systems. Anesth Analg 68: 377","journal-title":"Anesth Analg"},{"key":"BF02530129_CR30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/clpt.1988.159","volume":"44","author":"DS Weinberg","year":"1988","unstructured":"Weinberg DS, Inturrisi CE, Reidenberg B, Moulin DE, Nip TJ, Wallenstein S, Houde RW, Foley KM (1988) Sublingual absorption of selected opioid analgesics. Clin Pharmacol Ther 44: 335","journal-title":"Clin Pharmacol Ther"},{"key":"BF02530129_CR31","volume-title":"Therapie tumorbedingter Schmerzen","author":"WHO","year":"1988","unstructured":"WHO (1988) Therapie tumorbedingter Schmerzen. AV\u2014Kommunikation und Medizin, M\u00fcnchen"},{"key":"BF02530129_CR32","first-page":"39","volume":"12","author":"W Wolter","year":"1991","unstructured":"Wolter W, Zech D, Grond S, Gross-Fengels W, Lehmann A (1991) Medikament\u00f6se Schmerztherapie und CT-gesteuerte Alkoholneurolyse des Plexus Coeliacus beim Pankreaskarzinom. Eur J Pain 12: 39","journal-title":"Eur J Pain"},{"key":"BF02530129_CR33","first-page":"223","volume-title":"Palliative Krebstherapie","author":"D Zech","year":"1991","unstructured":"Zech D, Buzello W (1991) Schmerzbehandlung. In: Pichlmaier H (Hrsg) Palliative Krebstherapie Springer, Berlin Heidelberg New York, S 223"},{"key":"BF02530129_CR34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF02529122","volume":"1","author":"M Zenz","year":"1987","unstructured":"Zenz M (1987) Klinische Erfahrungen mit Buprenorphin. Der Schmerz 1: 48","journal-title":"Der Schmerz"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02530129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02530129\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02530129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T17:06:42Z","timestamp":1558285602000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02530129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,5]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,5]]}},"alternative-id":["BF02530129"],"URL":"https:\/\/doi.org\/10.1007\/bf02530129","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,5]]}}}